Steward Partners Investment Advisory’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.07K | Hold |
1,000
| – | – | ﹤0.01% | 3722 |
|
2025
Q1 | $2.2K | Hold |
1,000
| – | – | ﹤0.01% | 3622 |
|
2024
Q4 | $1.53K | Sell |
1,000
-110
| -10% | -$168 | ﹤0.01% | 3694 |
|
2024
Q3 | $2.21K | Sell |
1,110
-26,415
| -96% | -$52.6K | ﹤0.01% | 3422 |
|
2024
Q2 | $96.3K | Buy |
27,525
+26,525
| +2,653% | +$92.8K | ﹤0.01% | 1802 |
|
2024
Q1 | $2.77K | Hold |
1,000
| – | – | ﹤0.01% | 3226 |
|
2023
Q4 | $1.7K | Hold |
1,000
| – | – | ﹤0.01% | 3233 |
|
2023
Q3 | $1.03K | Hold |
1,000
| – | – | ﹤0.01% | 3186 |
|
2023
Q2 | $1.16K | Hold |
1,000
| – | – | ﹤0.01% | 3111 |
|
2023
Q1 | $1.51K | Hold |
1,000
| – | – | ﹤0.01% | 3069 |
|
2022
Q4 | $2.5K | Hold |
1,000
| – | – | ﹤0.01% | 2973 |
|
2022
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 2852 |
|
2022
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 2915 |
|
2022
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 2825 |
|
2021
Q4 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 2644 |
|
2021
Q3 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 2571 |
|
2021
Q2 | $16K | Sell |
1,000
-6,912
| -87% | -$111K | ﹤0.01% | 5392 |
|
2021
Q1 | $128K | Buy |
7,912
+6,912
| +691% | +$112K | ﹤0.01% | 1502 |
|
2020
Q4 | $21K | Sell |
1,000
-500
| -33% | -$10.5K | ﹤0.01% | 2034 |
|
2020
Q3 | $22K | Hold |
1,500
| – | – | ﹤0.01% | 1857 |
|
2020
Q2 | $22K | Hold |
1,500
| – | – | ﹤0.01% | 1731 |
|
2020
Q1 | $17K | Buy |
1,500
+500
| +50% | +$5.67K | ﹤0.01% | 1666 |
|
2019
Q4 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 1727 |
|
2019
Q3 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 1759 |
|
2019
Q2 | $18K | Buy |
+1,000
| New | +$18K | ﹤0.01% | 1746 |
|
2018
Q4 | – | Sell |
-1,000
| Closed | -$32K | – | 1373 |
|
2018
Q3 | $32K | Hold |
1,000
| – | – | ﹤0.01% | 1360 |
|
2018
Q2 | $39K | Hold |
1,000
| – | – | ﹤0.01% | 1197 |
|
2018
Q1 | $27K | Hold |
1,000
| – | – | ﹤0.01% | 1222 |
|
2017
Q4 | $18K | Buy |
+1,000
| New | +$18K | ﹤0.01% | 1159 |
|